As shutdown stalls IPOs, companies mull creative paths to market

As shutdown stalls IPOs, companies mull creative paths to market

Source: 
Biopharma Dive
News Tags: 
snippet: 

Biotechs in the process of going public are considering legal workarounds to bypass a hamstrung SEC, but the Nasdaq appears to be proceeding warily.